PCI completes acquisition of clinical trial services provider

Pharmaceutical outsourcing services provider acquires Australia-based Pharmaceutical Packaging Professionals, a clinical trial manufacturing, packaging, storage and distribution services provider

picture of

Breaking News

Wacker strengthens its pharmaceutical-protein business and buys Dutch biotech plant

Wacker Chemie AG has acquired a Dutch site to manufacture biopharmaceuticals, live microbial products and vaccines, ...

Cambrex invests in new continuous flow technology at its High Point (NC, USA) facility

Cambrex Corporation, the leading manufacturer of small molecule innovator and generic active pharmaceutical ingredients ...

Almac Group expands US specialised commercial packaging capabilities

Almac Group, the global contract pharmaceutical development and manufacturing organisation, is pleased to announce that ...

Biopharma boom brings benefits to CROs

The analytical outsourcing sector is well placed to benefit from the continuing rise in biopharmaceutical manufacturing

Recipharm has been recognised in the CMO Leadership Awards for 2018

Recipharm is a leading contract development and manufacturing organisation (CDMO) in the pharmaceutical industry, ...

Wacker opens new plant for functional silicone fluids in India

The company is expanding its existing silicone production site with a new hydrosilylation plant for manufacturing ...

Serialisation: one year and counting

The Falsified Medicines Directive (FMD) introduces pan-European measures to prevent counterfeit medicines from entering ...

Novacyt partners with Genepoc to diagnose respiratory infections

An international specialist in clinical diagnostics has entered into a clinical assay development contract with a ...

Sartorius supports ABL Europe to expand viral vector GMP capacity

A global technology player in the biopharma industry supports a supplier of viral vector manufacturing services to ...

Going conti: accelerating the speed of tablet production

The shift from batch to “conti” production could represent one of the largest paradigm shifts in pharma processing ...

Gene transfer therapy approved for the treatment of ALL: part I

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

FDA approves EU authorities to ensure public safety

Mutual Recognition Agreement (MRA) enables both EU and US regulators to use each other’s cGMP inspections of ...

Hovione expands capacity

Portugal's CDMO company has revealed further expansion plans at its sites in Portugal, Ireland and New Jersey

ReAgent grows with new eco-friendly factory

This April, ReAgent Chemical Services is tripling its manufacturing space with the opening of its new eco-friendly ...